SAREPTA THERAPEUTICS INC

Historical 13F Holders

CUSIP
803607AB6
All holders as of
Q3 2024
Type
Debt
Class
DBCV 1.500%11/1
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q3 19 59.1 M $101 M
2024 Q2 20 58.9 M $127 M
2024 Q1 23 62.2 M $111 M
2023 Q4 25 63.1 M $89.9 M
2023 Q3 21 63.4 M $113 M
2023 Q2 26 66.6 M $113 M
2023 Q1 27 58.7 M $117 M
2022 Q4 45 390 M $754 M
2022 Q3 43 396 M $673 M
2022 Q2 38 513 M $647 M
2022 Q1 40 550 M $724 M
2021 Q4 40 557 M $818 M
2021 Q3 46 559 M $829 M
2021 Q2 45 545 M $729 M
2021 Q1 44 559 M $735 M
2020 Q4 49 538 M $1.32 B
2020 Q3 46 528 M $1.10 B
2020 Q2 48 510 M $1.17 B
2020 Q1 45 521 M $801 M
2019 Q4 43 523 M $2.96 B
2019 Q3 41 539 M $712 M
2019 Q2 50 512 M $1.13 B
2019 Q1 40 521 M $941 M
2018 Q4 1 44.1 M $73.9 M